Results 81 to 90 of about 33,477 (277)

From cancer prevention to survivorship: Comprehensive menopause management after risk‐reducing salpingo‐oophorectomy

open access: yesInternational Journal of Gynecology &Obstetrics, EarlyView.
Abstract Risk‐reducing salpingo‐oophorectomy (RRSO) is the cornerstone of ovarian cancer prevention for women with hereditary cancer predisposition syndromes. When performed before natural menopause, however, RRSO induces immediate surgical menopause, with vasomotor symptoms, sexual dysfunction, accelerated bone loss, and potential long‐term ...
Agnaldo Lopes da Silva Filho   +7 more
wiley   +1 more source

Progesterone, Progestins, and the Heart

open access: yesReviews in Cardiovascular Medicine, 2010
All combination hormone replacement regimens contain estrogen and a progestational agent. The Women's Health Initiative trial demonstrated that taking the combination of conjugated estrogen and medroxyprogesterone resulted in a higher risk of myocardial infarction and stroke in the study population.
Paula, Bernstein, Gerald, Pohost
openaire   +3 more sources

Risk‐reducing gynecologic surgery in hereditary cancer: Evidence, timing, and counseling

open access: yesInternational Journal of Gynecology &Obstetrics, EarlyView.
Abstract Risk‐reducing gynecologic surgery is an established preventive option for women with selected hereditary cancer predisposition syndromes. In BRCA1 and BRCA2 pathogenic variant carriers, observational studies associate risk‐reducing salpingo‐oophorectomy with lower tubo‐ovarian cancer incidence and mortality.
Agnaldo Lopes da Silva Filho   +7 more
wiley   +1 more source

Dienogest vs. Leuprolide Asetat pada Endometriosis: Sebuah Meta-Analisis

open access: yesJurnal Anestesi Obstetri Indonesia
Latar Belakang: Endometriosis merupakan penyakit ginekologi kronis yang menyebabkan nyeri panggul dan menurunkan kualitas hidup. Dienogest diperkirakan memiliki efektivitas serupa dengan analog gonadotropin-releasing hormone (GnRH) seperti leuprolide ...
Gilang Rizqy Perdana Aries Rohman   +2 more
doaj   +1 more source

Figure S8 from Progestin Significantly Inhibits Carcinogenesis in the Mogp-TAg Transgenic Mouse Model of Fallopian Tube Cancer

open access: yes, 2022
Figure S8 shows the chemoprevention model of progestin.
Omar L. Nelson (15108392)   +5 more
core   +1 more source

Pelvic Ultrasound for Predicting Endometrial Neoplasia in Premenopausal Abnormal Uterine Bleeding

open access: yesJournal of Ultrasound in Medicine, EarlyView.
Objectives Although ultrasound is the first line imaging modality for abnormal uterine bleeding (AUB), there is a lack of consensus on its predictiveness for premenopausal endometrial pathology. This study aims to determine the predictiveness of pelvic ultrasound for endometrial neoplasia and cancer precursor lesions in premenopausal patients ...
Jessica Grubman   +7 more
wiley   +1 more source

The Role Of Progestogens In Threatened And Idiopathic Recurrent Miscarriage

open access: yesInternational Journal of Women's Health, 2019
Hisham Arab,1 Ahmed Jaber Alharbi,2 Ayman Oraif,3 Emad Sagr,4 Hana Al Madani,5 Hassan Abduljabbar,3 Osama Sadeak Bajouh,3 Yaser Faden,6 Yasser Sabr7 1Obstetrics and Gynecology Department, Dr.
Arab H   +8 more
doaj  

Menstrual suppression to decrease intrauterine device expulsion in adolescents with inherited bleeding disorders

open access: yes
International Journal of Gynecology &Obstetrics, Volume 169, Issue 1, Page 421-423, April 2025.
Peter H. Cygan   +3 more
wiley   +1 more source

Hsp90 Inhibition on the Western Blot: N‐Terminal Versus C‐Terminal Inhibitors in Breast Cancer

open access: yesMedicinal Research Reviews, EarlyView.
ABSTRACT Heat shock protein 90 (Hsp90) is an established and clinically validated anticancer target. By regulating the folding and maturation of diverse client proteins, it is indirectly involved in carcinogenesis. Key breast cancer oncogenic drivers, including estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2, are ...
Jaka Dernovšek   +3 more
wiley   +1 more source

Verification of the utility of the gonadotropin starting dose calculator in progestin‐primed ovarian stimulation: A comparison of empirical and calculated controlled ovarian stimulation

open access: yesReproductive Medicine and Biology
Purpose To validate the effectiveness of a gonadotropin starting dose calculator for progestin‐primed ovarian stimulation (PPOS), we conducted a study comparing the outcomes of oocyte retrieval between a group assigned gonadotropin doses via the ...
Masato Kobanawa, Jouji Yoshida
doaj   +1 more source

Home - About - Disclaimer - Privacy